This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.
Otherwise, enjoy the column!
Subscribe to The Market Chronicle to get the Daily Monster Market Commentary and join the 2,893 subscribers getting it for FREE!
#Macro – $SPX, #Rates, #CPI
- RTM: Stocks Pause Ahead Of CPI Report
- RTM Unusual Options Activity: S&P 500 May Be Heading Back Below 4,200
- RTM: The Call Wall At 4,400 Remain Resistance
- RTM: Powell Follow Up
- RTM: 30-Year Auction Rapid Update (Audio)
- RTM: Stocks Stall As Gamma Squeeze Losses Juice
- RTM: Stocks Contained By Options, Despite A Solid 3-Year Auction
Stocks finished lower ahead of tomorrow’s CPI report. Expectations are for headline CPI to increase by 0.1% m/m and 3.3% y/y, down from September’s increase of 0.4% m/m and 3.7% y/y reading. Core CPI is expected to rise by 0.3% m/m and 4.1% y/y, in line with last month’s reading.
The core CPI, if it comes in as expected at 0.3%, would be a number not consistent with the Fed 2% target, and more importantly, it does run the risk of coming in hotter than expected given the reset in the Health Insurance piece, which feeds into the Hospital and Related services and the broader Medical care services. The weighting for medical care services is about 6.3% in headline CPI and higher in the core CPI. That will be the sector to watch tomorrow because the days of health insurance falling by 3 to 4% per month will be gone, and we should see health insurance rise by 1 to 2% per month. Currently, with a weight of 0.545% in CPI, the Health Insurance will go from subtracting from Medical care services and will become addictive. Medical services did start rising again after months of falling, and the health insurance component could add to this change in trend if it should persist.
Meanwhile, 10-year rate appears to be ready to go higher from current levels, as they hold the uptrend and support at the 4.5% level. In the meantime, a move above 4.7% could push the 10-year back to 5%.
Subscribe to the The Market Chronicle to get it Daily and join the 2,893 subscribers getting it for FREE!
Additionally, the gap between 10-year bond prices and the S&P 500 widens. The two have done this four times, and this would be the fifth. The prior four times saw the two diverge for about 5 to 7 days, and today was day 5, so if they are going to come together, the gap should close soon.
The stock market doesn’t seem concerned about tomorrow’s inflation print with a VIX sub-15. But with Vixperation on Wednesday morning, you have to wonder if the market will let all these puts expire in the money or if they will creep the VIX higher to burn off the delta and gamma below 18 and push the VIX up.
Meanwhile, the S&P 500 remains pegged to the 4,400 region as we approach opex, as gamma builds up at the 4,400 strike price, making it hard for the S&P 500 to escape from that region, at least today. That, of course, could change tomorrow, depending on the CPI report. There is a lot of positive delta on the board for Friday’s OPEX, and if we do get a hot CPI report tomorrow, and the indexes do start to move lower, the value of call options will start decaying quickly, and that will mean there will market makers would have a lot of stock to unhedge, meaning bringing it for sale.
Technically, nothing changed for the S&P 500 today, and the gaps at 4,100 are still left to be filled; the technical pattern of the cup with a rising handle is still present, suggesting lower prices to come, while the 61.8% retracement still acts as resistance.
Anyway, we will have to see what tomorrow brings. Again, the setup for a reversal seems to be there, and the data point could favor it. Now, it is just a question of whether it happens or not.
Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.